Back to Search
PHILIP CARROLL, M.D.
M.D.
Family Medicine Physician
NPI: 1750635652Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
11813(NH)
Research & Publications (20)
Combined growth hormone/insulin-like growth factor I in addition to glutamine-supplemented TPN results in net protein anabolism in critical illness.
PMID 12759221·Am J Physiol Endocrinol Metab·2004
3-trial
Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
PMID 15292323·J Clin Endocrinol Metab·2004
3-trial
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
PMID 14725677·Clin Endocrinol (Oxf)·2004
8-other
Factors determining the remission of microprolactinomas after dopamine agonist withdrawal.
PMID 19549247·Clin Endocrinol (Oxf)·2010
8-other
The independent value of tumour volume in a contemporary cohort of men treated with radical prostatectomy for clinically localized disease.
PMID 19681901·BJU Int·2010
8-other
Adequacy of lymphadenectomy among men undergoing robot-assisted laparoscopic radical prostatectomy.
PMID 19549119·BJU Int·2010
8-other
Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy.
PMID 19375843·Eur Urol·2010
8-other
Are age-based criteria the best way to determine eligibility for prostate cancer screening?
PMID 19189916·Ann Intern Med·2009
8-other
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer.
PMID 19150582·Eur Urol·2009
1-meta
Applications of 1-alkenyl-1,1-heterobimetallics in the stereoselective synthesis of cyclopropylboronate esters, trisubstituted cyclopropanols and 2,3-disubstituted cyclobutanones.
PMID 19382808·J Am Chem Soc·2009
8-other
Maximum vs. mono androgen blockade and the risk of recurrence in men with localized prostate cancer undergoing brachytherapy.
PMID 19233568·Int J Radiat Oncol Biol Phys·2009
4-observational
Outcomes and follow-up strategies for patients on active surveillance.
PMID 19295434·Curr Opin Urol·2009
6-review
Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
PMID 19245716·BMC Cancer·2009
8-other
Expectations for others' outcomes: do people display compassionate bracing?
PMID 19060220·Pers Soc Psychol Bull·2009
8-other
Collagens in the developing and diseased nervous system.
PMID 19031044·Cell Mol Life Sci·2009
6-review
Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease.
PMID 19230923·J Urol·2009
8-other
Highly enantio- and diastereoselective one-pot methods for the synthesis of halocyclopropyl alcohols.
PMID 19154172·J Am Chem Soc·2009
8-other
Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
PMID 19215030·Cancer·2009
8-other
A multicolour fluorescence in situ hybridization test predicts recurrence in patients with high-risk superficial bladder tumours undergoing intravesical therapy.
PMID 19220253·BJU Int·2009
8-other
Pathological outcomes of candidates for active surveillance of prostate cancer.
PMID 19233388·J Urol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 31 TAGGARD RD
WALPOLE, NH 03608 - Phone
- (603) 756-3587
Quick Facts
- NPI
- 1750635652
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile